Xencor Inc.

Xencor Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.65
Market Cap
$2.48 B
Shares Outstanding
56.35 M
Public Float
55.56 M

Profile

Address
111 West Lemon Avenue
Monrovia California 91016
United States
Employees -
Website http://www.xencor.com
Updated 07/08/2019
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I.

Financials

View All
Created with Highcharts 5.0.14Xencor Inc.Net Income. Fiscal year is January-December. All values USD Thousands.84 50684 50616 42216 42217 59217 59223 62523 62548 92548 92570 40970 409201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Xencor Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.10 17210 1729 5209 52027 76227 76287 52087 52035 71135 71140 60340 603201320142015201620172018020k40k60k80k100k

Bassil I. Dahiyat
President, Chief Executive Officer & Director
Richard J. Ranieri
Independent Director